|
|
 |
 |
 |
 |
 |
Sanaz Saatchi
Bioengineering
Amgen Fellow
Professors Charles Taylor (Bioengineering) and Paul Yock (Bioengineering)
Abdominal aortic aneurysms (AAA) are a life-threatening degenerative disease. A better understanding of the pathological mechanisms that lead to aneurysm formation is essential for the development of effective preventative therapies. Through the use of a novel high resolution imaging technology, coupled with computational analysis and molecular biology techniques, Sanaz’s work with the laboratories of Charles Taylor and Paul Yock will characterize the three-dimensional nanometric tissue structure changes and biological events occurring within a blood vessel wall during aneurysm development in an unprecedented manner. These studies will improve their understanding of aneurysm development and may assist in the identification of potential therapeutic targets. |
 |
|
 |
|
|